T1	SectionAnnotate 273 277	HPI:
T2	SectionAnnotate 6374 6395	Past Medical History:
T3	SectionAnnotate 6500 6522	Past Surgical History:
T4	SectionAnnotate 6588 6602	Family History
T5	SectionAnnotate 6695 6709	Social History
T6	SectionAnnotate 8057 8081	Social History Narrative
T7	SectionSkip 8335 8824	Encounter Medications as of 01/28/2019   Medication Sig Dispense Refill    gabapentin (NEURONTIN) 300 mg capsule       hydroCHLOROthiazide (HYDRODIURIL) 25 mg tablet Take 25 mg by mouth.      [DISCONTINUED] polymyxin b-trimethoprim (POLYTRIM) ophthalmic solution Affected eye for 5 days (Patient not taking: Reported on 12/28/2018) 10 mL 0    [EXPIRED] iohexol (OMNIPAQUE) 350 mg iodine/mL solution 150 mL        No facility-administered encounter medications on file as of 01/28/2019.
T8	SectionAnnotate 8935 8952	Review of Systems
T10	SectionSkip 9411 9425	Physical Exam:
T11	SectionAnnotate 10737 10768	Assessment and Recommendations:
T12	PROBLEM 76 90	a Stage III HR
T13	PROBLEM 92 96	HER2
T14	PROBLEM 98 120	IDC of the left breast
T15	TEST 131 137	biopsy
T16	PROBLEM 145 155	recurrence
T17	TREATMENT 199 216	treatment options
T18	PROBLEM 320 333	breast cancer
T19	PROBLEM 363 388	a mass in her left breast
T20	TEST 411 418	Imaging
T21	PROBLEM 447 484	a hypoechoic focus in her left breast
T22	TEST 489 511	subsequent evaluations
T23	TEST 534 538	a HR
T24	TREATMENT 591 624	bilateral skin-sparing mastectomy
T25	TREATMENT 640 653	adjuvant ddAC
T26	PROBLEM 689 716	intolerance of side-effects
T27	TREATMENT 777 787	leuprolide
T28	TREATMENT 793 803	exemestane
T29	TREATMENT 824 834	leuprolide
T30	TREATMENT 840 849	tamoxifen
T31	TREATMENT 855 867	this therapy
T32	TREATMENT 918 947	her health insurance coverage
T33	PROBLEM 977 995	a left breast mass
T34	TEST 1000 1015	a subsequent US
T35	TEST 1020 1026	biopsy
T36	TEST 1040 1044	a HR
T37	TEST 1103 1113	evaluation
T38	TEST 1148 1167	Bilateral breast US
T39	PROBLEM 1169 1225	Irregular somewhat scalloped appearning hypoechoic focus
T40	TEST 1236 1258	left axillary tail  US
T41	TEST 1259 1277	guided core biopsy
T42	PROBLEM 1281 1303	2.2 cm palpable nodule
T43	TEST 1341 1364	micropapillary features
T44	TEST 1394 1396	PR
T45	TEST 1422 1426	HER2
T46	TEST 1429 1439	FISH ratio
T47	TEST 1446 1451	Ki-67
T48	TEST 1468 1506	Bilateral diagnostic digital mammogram
T49	PROBLEM 1508 1568	Extensive, segmentally distributed, clustered calcifications
T50	PROBLEM 1627 1685	associated focal, poorly defined, dense and irregular mass
T51	PROBLEM 1807 1846	focal, nodular thickening of parenchyma
T52	TEST 1868 1870	US
T53	TEST 1878 1901	left axillary LN biopsy
T54	PROBLEM 1903 1923	Metastatic carcinoma
T55	TEST 1959 1961	PR
T56	TEST 1987 1991	HER2
T57	TEST 1994 2004	FISH ratio
T58	TEST 2012 2017	Ki-67
T59	TREATMENT 2034 2074	Bilateral breast skin-sparing mastectomy
T60	TREATMENT 2077 2095	left axillary SLNB
T61	TREATMENT 2101 2118	DIEP: left breast
T62	PROBLEM 2128 2159	grade 2 IDC micropapillary type
T63	PROBLEM 2195 2226	intermediate nuclear grade DCIS
T64	TEST 2241 2243	LN
T65	TEST 2258 2281	extracapsular extension
T66	TEST 2283 2289	pT3pN2
T67	PROBLEM 2309 2318	carcinoma
T68	TEST 2331 2351	Whole body bone scan
T69	PROBLEM 2353 2422	Usual symmetric radiotracer uptake in axial and appendicular skeleton
T70	PROBLEM 2459 2477	metastatic disease
T71	TEST 2491 2493	CT
T72	PROBLEM 2514 2524	metastases
T73	TREATMENT 2551 2567	dense Adriamycin
T74	TREATMENT 2568 2575	cytoxan
T75	TREATMENT 2594 2610	active treatment
T76	PROBLEM 2632 2645	severe nausea
T77	PROBLEM 2647 2655	vomiting
T78	PROBLEM 2657 2663	fevers
T79	PROBLEM 2665 2671	chills
T80	PROBLEM 2683 2702	diffused body pains
T81	TEST 2726 2732	CT CAP
T82	PROBLEM 2734 2754	Soft tissue swelling
T83	TREATMENT 2758 2790	bilateral breast reconstructions
T84	PROBLEM 2799 2833	obvious loculated fluid collection
T85	TREATMENT 2837 2876	visualized lower breast reconstructions
T86	PROBLEM 2888 2908	abdominoplasty wound
T87	PROBLEM 2929 2942	a sinus tract
T88	PROBLEM 2987 2992	fluid
T89	PROBLEM 3015 3025	induration
T90	PROBLEM 3030 3050	soft tissue swelling
T91	TEST 3071 3090	Bilateral breast US
T92	PROBLEM 3092 3144	Moderate bilateral subcutaneous soft tissue swelling
T93	PROBLEM 3161 3187	loculated fluid collection
T94	TEST 3201 3203	CT
T95	PROBLEM 3227 3284	mildly hypermetabolic right deep pectoral and axillary LN
T96	TEST 3293 3311	short axis MAX suv
T97	PROBLEM 3318 3357	mildly hypermetabolic right axillary LN
T98	TEST 3363 3381	short axis MAX suv
T99	PROBLEM 3407 3451	right outer lower breast central fat density
T100	TEST 3466 3473	SUV max
T101	PROBLEM 3500 3512	fat necrosis
T102	TEST 3585 3587	US
T103	TEST 3595 3617	right breast LN biopsy
T104	PROBLEM 3619 3651	Benign axillary node hyperplasia
T105	TREATMENT 3678 3684	Lupron
T106	TREATMENT 3702 3733	exemestane and latera tamoxifen
T107	TEST 3759 3761	CT
T108	PROBLEM 3772 3789	pulmonary embolus
T109	PROBLEM 3793 3816	other acute abnormality
T110	TEST 3830 3842	Bilateral US
T111	PROBLEM 3873 3890	right axillary LN
T112	PROBLEM 3916 3945	decreased cortical thickening
T113	PROBLEM 4028 4046	a left breast lump
T114	PROBLEM 4070 4102	darkening of the associated skin
T115	TEST 4117 4131	Left breast US
T116	PROBLEM 4145 4175	Irregular lobulated solid mass
T117	PROBLEM 4202 4218	a satellite mass
T118	PROBLEM 4276 4280	mass
T119	TEST 4302 4320	overlying skin  US
T120	TEST 4321 4334	guided biopsy
T121	PROBLEM 4338 4342	mass
T122	TEST 4399 4401	PR
T123	TEST 4410 4414	HER2
T124	TEST 4417 4420	IHC
T125	TEST 4425 4430	Ki-67
T126	TEST 4451 4457	PET/CT
T127	PROBLEM 4459 4488	Left breast subcutaneous mass
T128	TEST 4503 4506	SUV
T129	TEST 4513 4531	left axillary node
T130	TEST 4546 4549	SUV
T131	TEST 4556 4585	left level 5B LN conglomerate
T132	TEST 4600 4603	SUV
T133	TEST 4611 4635	left internal mammary LN
T134	TEST 4650 4653	SUV
T135	PROBLEM 4660 4755	left axillary, left supraclavicular, left level VB and left internal mammary hypermetabolic LAD
T136	PROBLEM 4775 4792	metastatic diease
T137	PROBLEM 4794 4854	hypermetabolic subcutaneous masses overlying the left breast
T138	PROBLEM 5109 5136	irregular menstrual periods
T139	PROBLEM 5190 5215	multiple medical problems
T140	TREATMENT 5343 5353	gapabentin
T141	PROBLEM 5358 5366	numbness
T142	PROBLEM 5371 5401	a deep sharp pain of her elbow
T143	TREATMENT 5443 5457	The medication
T144	PROBLEM 5523 5531	the pain
T145	PROBLEM 5553 5561	the pain
T146	PROBLEM 5600 5617	chronic back pain
T147	PROBLEM 5622 5672	occasional aches of her bilateral knees and ankles
T148	TREATMENT 5710 5727	Lupron injections
T149	PROBLEM 5750 5771	her menstrual periods
T150	TREATMENT 5810 5831	the Lupron injections
T151	TREATMENT 5893 5902	tamoxifen
T152	TREATMENT 5907 5917	exemestane
T153	PROBLEM 5935 5941	nausea
T154	PROBLEM 5946 5955	body pain
T155	PROBLEM 5994 6005	her disease
T156	PROBLEM 6058 6085	the mass on her left breast
T157	PROBLEM 6122 6157	a some discoloration above the mass
T158	PROBLEM 6169 6197	a lump on her left neck area
T159	PROBLEM 6232 6265	an injury from straining her neck
T160	TEST 6271 6281	Her weight
T161	PROBLEM 6310 6323	a sweet tooth
T162	PROBLEM 6417 6436	Breast cancer (HCC)
T163	PROBLEM 6446 6464	HTN (hypertension)
T164	PROBLEM 6470 6492	Hyperemesis gravidarum
T165	TREATMENT 6525 6565	Procedure Laterality Date    MASTECTOMY
T166	PROBLEM 6644 6652	Lymphoma
T167	PROBLEM 6666 6679	Breast cancer
T168	TREATMENT 8345 8356	Medications
T169	TREATMENT 8411 8433	gabapentin (NEURONTIN)
T170	TREATMENT 8456 8489	hydroCHLOROthiazide (HYDRODIURIL)
T171	TREATMENT 8531 8613	DISCONTINUED] polymyxin b-trimethoprim (POLYTRIM) ophthalmic solution Affected eye
T172	TREATMENT 8683 8711	EXPIRED] iohexol (OMNIPAQUE)
T173	TREATMENT 8787 8798	medications
T174	PROBLEM 8832 8841	Allergies
T175	TREATMENT 8862 8880	Allergen Reactions
T176	TREATMENT 8885 8910	Hydrocodone-Acetaminophen
T177	TREATMENT 8916 8925	Ibuprofen
T178	PROBLEM 8984 8995	weight loss
T179	PROBLEM 9145 9172	Irregular menstrual periods
T180	PROBLEM 9205 9215	joint pain
T181	PROBLEM 9224 9253	Bilateral knee and ankle ache
T182	PROBLEM 9269 9305	Discoloration of skin on left breast
T183	PROBLEM 9329 9337	Numbness
T184	TEST 9429 9440	Vital Signs
T185	TEST 9443 9445	BP
T186	TEST 9456 9461	Pulse
T187	TEST 9468 9472	Temp
T188	TEST 9478 9479	C
T189	TEST 9501 9505	Resp
T190	TEST 9512 9514	Ht
T191	TEST 9602 9606	SpO2
T192	TEST 9614 9617	BMI
T193	PROBLEM 9655 9658	NAD
T194	PROBLEM 9674 9683	anicteric
T195	PROBLEM 9713 9722	nontender
T196	PROBLEM 9761 9769	erythema
T197	PROBLEM 9773 9783	stomatitis
T198	PROBLEM 9788 9808	thrush   Lymph Nodes
T199	PROBLEM 9815 9868	cervical, supraclavicular or axillary lymphadenopathy
T200	TEST 9896 9906	percussion
T201	TEST 9919 9922	CTA
T202	PROBLEM 9939 9946	wheezes
T203	PROBLEM 9948 9955	rhonchi
T204	PROBLEM 9960 9968	crackles
T205	PROBLEM 10024 10031	murmurs
T206	PROBLEM 10036 10041	edema
T207	PROBLEM 10078 10096	a  6.5 x 5 cm mass
T208	PROBLEM 10226 10273	3.5 x 3.5 cm mass in left lateral anterior neck
T209	PROBLEM 10311 10321	tenderness
T210	PROBLEM 10326 10336	distention
T211	PROBLEM 10341 10344	HSM
T212	PROBLEM 10367 10398	tenderness over bones or joints
T213	PROBLEM 10519 10521	HI
T214	PROBLEM 10523 10525	SI
T215	PROBLEM 10527 10541	hallucinations
T216	PROBLEM 10543 10551	paranoia
T217	PROBLEM 10556 10565	delusions
T218	PROBLEM 10587 10593	rashes
T219	PROBLEM 10597 10604	lesions
T220	TEST 10619 10633	Available labs
T221	TEST 10635 10644	pathology
T222	TEST 10650 10657	imaging
T223	PROBLEM 10825 10846	a Stage III (T3N2) HR
T224	TEST 10848 10852	HER2
T225	PROBLEM 10854 10865	grade 2 IDC
T226	PROBLEM 10871 10913	micropapillary features of the left breast
T227	PROBLEM 10924 10967	a locally advanced, unresectable recurrence
T228	PROBLEM 10989 10999	metastatic
T229	TEST 11043 11064	additional evaluation
T230	TREATMENT 11083 11099	systemic therapy
T231	PROBLEM 11218 11230	recurrent HR
T232	PROBLEM 11238 11251	breast cancer
T233	TREATMENT 11301 11331	the multidisciplinary approach
T234	TREATMENT 11335 11358	breast cancer treatment
T235	TEST 11361 11371	Her PET/CT
T236	PROBLEM 11385 11417	uptake in a level Vb lymph nodes
T237	PROBLEM 11443 11461	metastatic disease
T238	PROBLEM 11475 11486	her disease
T239	TREATMENT 11536 11552	systemic therapy
T240	TEST 11567 11573	an FNA
T241	TEST 11680 11682	HR
T242	PROBLEM 11690 11693	MBC
T243	TREATMENT 11753 11773	prolongation of life
T244	PROBLEM 11824 11844	excessive toxicities
T245	TREATMENT 11872 11892	chemotherapy upfront
T246	TREATMENT 11960 11972	chemotherapy
T247	TREATMENT 12031 12080	the standard first line endocrine-based treatment
T248	PROBLEM 12085 12107	premenopausal patients
T249	TREATMENT 12113 12120	HR+ MBC
T250	PROBLEM 12124 12143	ovarian suppression
T251	TREATMENT 12149 12171	an aromatase inhibitor
T252	TREATMENT 12207 12226	a CDK 4/6 inhibitor
T253	TREATMENT 12261 12263	OS
T254	TREATMENT 12337 12344	therapy
T255	TREATMENT 12408 12430	additional medications
T256	TREATMENT 12543 12552	goserelin
T257	TREATMENT 12819 12837	the treatment plan
T258	TREATMENT 12854 12870	medication risks
T259	TREATMENT 12872 12894	lifestyle modification
T260	TREATMENT 12922 12929	surgery
T261	PROBLEM 12931 12939	symptoms
T262	TREATMENT 12944 12963	therapeutic options
T263	PatientCharacteristics 29 42	premenopausal
T264	Age 21 23	31
T265	Stage 84 87	III
T266	Histology 98 101	IDC
T267	Site 114 120	breast
T268	Laterality 109 113	left
R1	LateralityOfSite Arg1:T268 Arg2:T267	
R2	SiteOf Arg1:T267 Arg2:T266	
T269	BiomarkerName 92 96	HER2
T270	BiomarkerName 88 90	HR
T271	BiomarkerResult 90 91	+
A1	BiomarkerResultVal T271 Positive
T272	BiomarkerResult 96 97	-
A2	BiomarkerResultVal T272 Negative
R3	BiomarkerRel Arg1:T272 Arg2:T269	
R4	BiomarkerRel Arg1:T270 Arg2:T271	
A3	HistoryVal T266 history
A4	EpisodeDescription T266 FirstOccurrence
T273	Pathology 131 137	biopsy
A5	IntentVal T273 diagnosis
T274	DiseaseState 145 155	recurrence
T275	ClinicalCondition 320 333	breast cancer
T276	Datetime 342 346	2013
R6	BeginsOnOrAt Arg1:T275 Arg2:T276	
T277	Symptom 365 369	mass
A7	IsPresentOnFirstCancerDiagnosis T277 yes
A8	IsCausedByDiagnosedCancer T277 yes
T278	Site 382 388	breast
T279	Laterality 377 381	left
R7	LateralityOfSite Arg1:T279 Arg2:T278	
R8	SiteOf Arg1:T278 Arg2:T277	
R9	ConditionOrTreatmentCausesProblem Treatment:T275 Prob:T277	
T280	Radiology 411 418	Imaging
A9	IntentVal T280 diagnosis
T281	Datetime 422 433	August 2013
R10	HappensAtOnDuring Arg1:T280 Arg2:T281	
T282	RadPathResult 449 465	hypoechoic focus
A10	RadPathResultVal T282 InitialCancerDiagnosis
T283	Laterality 473 477	left
T284	Site 478 484	breast
R11	LateralityOfSite Arg1:T283 Arg2:T284	
R12	SiteOf Arg1:T284 Arg2:T282	
R13	ResultOfTest Desc:T282 Test:T280	
T285	Histology 546 549	IDC
A11	HistoryVal T285 history
A12	EpisodeDescription T285 FirstOccurrence
T286	Site 562 568	breast
T287	Laterality 557 561	left
R14	LateralityOfSite Arg1:T287 Arg2:T286	
R15	SiteOf Arg1:T286 Arg2:T285	
T288	BiomarkerName 536 538	HR
A13	HistoryVal T288 history
A14	EpisodeDescription T288 FirstOccurrence
T289	BiomarkerName 540 544	HER2
A15	HistoryVal T289 history
A16	EpisodeDescription T289 FirstOccurrence
T290	BiomarkerResult 538 539	+
A17	HistoryVal T290 history
A18	EpisodeDescription T290 FirstOccurrence
A19	BiomarkerResultVal T290 Positive
R16	BiomarkerRel Arg1:T288 Arg2:T290	
T291	BiomarkerResult 544 545	-
A20	HistoryVal T291 history
A21	EpisodeDescription T291 FirstOccurrence
A22	BiomarkerResultVal T291 Negative
R17	BiomarkerRel Arg1:T289 Arg2:T291	
T292	TumorTest 500 511	evaluations
A23	IntentVal T292 DiagnosisAndTreatment
A24	GenomicTestType T292 Unclear
R18	TestOrProcedureConductedForProblem Test:T280 Prob:T277	
R19	TestOrProcedureConductedForProblem Test:T292 Prob:T277	
R20	TestOrProcedureReveals Test:T292 Desc:T288	
R21	TestOrProcedureReveals Test:T292 Desc:T288	
R22	TestOrProcedureReveals Test:T292 Desc:T285	
T293	ProcedureName 601 624	skin-sparing mastectomy
A25	IntentVal T293 treatment-curative
A26	TreatmentTypeVal T293 local
A27	IsTumorRemaining T293 no
T294	Site 591 600	bilateral
R23	SiteOf Arg1:T294 Arg2:T293	
R24	TestOrProcedureConductedForProblem Test:T293 Prob:T285	
T295	MedicationRegimen 649 653	ddAC
A28	TreatmentContinuityVal T295 discontinued_early
A29	TreatmentTypeVal T295 adjuvant
A30	TreatmentIntentVal T295 curative
T296	Cycles 673 674	3
R25	TreatmentDesc Therapy:T296 Desc:T295	
R26	TreatmentAdministeredForProblem Treatment:T295 Prob:T285	
T297	Symptom 704 716	side-effects
A31	IsPresentOnFirstCancerDiagnosis T297 no
A32	IsCausedByDiagnosedCancer T297 no
R27	TreatmentDiscontinuedBecauseOf Therapy:T295 Reason:T297	
T298	MedicationName 777 787	leuprolide
A33	TreatmentContinuityVal T298 discontinued_early
A34	TreatmentTypeVal T298 adjuvant
A35	TreatmentIntentVal T298 curative
A36	TreatmentCategory T298 AntiNeoPlastics
T299	MedicationName 793 803	exemestane
A37	TreatmentContinuityVal T299 discontinued_early
A38	TreatmentTypeVal T299 adjuvant
A39	TreatmentIntentVal T299 curative
A40	TreatmentCategory T299 AntiNeoPlastics
T300	MedicationName 824 834	leuprolide
A41	TreatmentContinuityVal T300 discontinued_early
A42	TreatmentTypeVal T300 adjuvant
A43	TreatmentIntentVal T300 curative
A44	TreatmentCategory T300 AntiNeoPlastics
T301	MedicationName 840 849	tamoxifen
A45	TreatmentContinuityVal T301 discontinued_early
A46	TreatmentTypeVal T301 adjuvant
A47	TreatmentIntentVal T301 curative
A48	TreatmentCategory T301 AntiNeoPlastics
T302	Duration 882 891	1-2 years
T303	Insurance 922 938	health insurance
R28	TreatmentAdministeredForProblem Treatment:T298 Prob:T285	
R29	TreatmentAdministeredForProblem Treatment:T299 Prob:T285	
R30	TreatmentAdministeredForProblem Treatment:T300 Prob:T285	
R31	TreatmentAdministeredForProblem Treatment:T301 Prob:T285	
R32	HappensAtOnDuring Arg1:T300 Arg2:T302	
R33	HappensAtOnDuring Arg1:T301 Arg2:T302	
R34	TreatmentDiscontinuedBecauseOf Therapy:T300 Reason:T303	
R35	TreatmentDiscontinuedBecauseOf Therapy:T301 Reason:T303	
T304	Datetime 957 966	June 2019
T305	Symptom 991 995	mass
A49	IsPresentOnFirstCancerDiagnosis T305 yes
A50	IsCausedByDiagnosedCancer T305 yes
A51	ContinuityVal T305 worsening
T306	Site 984 990	breast
T307	Laterality 979 983	left
R36	LateralityOfSite Arg1:T307 Arg2:T306	
R37	SiteOf Arg1:T306 Arg2:T305	
T308	Radiology 1013 1015	US
A52	IntentVal T308 diagnosis
T309	Pathology 1020 1026	biopsy
A53	IntentVal T309 diagnosis
R38	TestOrProcedureConductedForProblem Test:T308 Prob:T305	
R39	TestOrProcedureConductedForProblem Test:T309 Prob:T305	
T310	Histology 1052 1055	IDC
A54	HistoryVal T310 new
A55	EpisodeDescription T310 Recurrence
T311	BiomarkerName 1042 1044	HR
A56	HistoryVal T311 new
A57	EpisodeDescription T311 Recurrence
T312	BiomarkerName 1046 1050	HER2
A58	HistoryVal T312 new
A59	EpisodeDescription T312 Recurrence
T313	BiomarkerResult 1044 1045	+
A60	HistoryVal T313 new
A61	EpisodeDescription T313 Recurrence
A62	BiomarkerResultVal T313 Positive
T314	BiomarkerResult 1050 1051	-
A63	HistoryVal T314 new
A64	EpisodeDescription T314 Recurrence
A65	BiomarkerResultVal T314 Negative
R40	BiomarkerRel Arg1:T313 Arg2:T311	
R41	BiomarkerRel Arg1:T314 Arg2:T312	
R42	TestOrProcedureReveals Test:T309 Desc:T310	
R43	TestOrProcedureReveals Test:T309 Desc:T312	
R44	TestOrProcedureReveals Test:T309 Desc:T311	
T315	Site 1068 1074	breast
T316	Laterality 1063 1067	left
R45	LateralityOfSite Arg1:T316 Arg2:T315	
R46	SiteOf Arg1:T315 Arg2:T310	
T317	Datetime 1139 1147	08/03/13
T318	Radiology 1165 1167	US
A66	IntentVal T318 diagnosis
T319	Site 1158 1164	breast
T320	Laterality 1148 1157	Bilateral
R47	LateralityOfSite Arg1:T320 Arg2:T319	
R48	SiteOf Arg1:T319 Arg2:T318	
R49	HappensAtOnDuring Arg1:T317 Arg2:T318	
T321	RadPathResult 1169 1225	Irregular somewhat scalloped appearning hypoechoic focus
A67	RadPathResultVal T321 InitialCancerDiagnosis
T322	Size 1227 1231	2 cm
A68	HistoryVal T322 history
A69	EpisodeDescription T322 FirstOccurrence
T323	Laterality 1236 1240	left
T324	Site 1241 1254	axillary tail
R50	LateralityOfSite Arg1:T323 Arg2:T324	
R51	SiteOf Arg1:T324 Arg2:T321	
R52	ResultOfTest Desc:T321 Test:T318	
T325	Pathology 1256 1277	US-guided core biopsy
A70	IntentVal T325 diagnosis
R53	HappensAtOnDuring Arg1:T325 Arg2:T317	
T326	Size 1281 1287	2.2 cm
A71	HistoryVal T326 history
A72	EpisodeDescription T326 FirstOccurrence
T327	Site 1307 1318;1324 1330	upper-outer breast
T328	Laterality 1319 1323	left
R54	LateralityOfSite Arg1:T328 Arg2:T327	
R55	SiteOf Arg1:T327 Arg2:T325	
T329	Histology 1332 1335;1341 1364	IDC micropapillary features
A73	HistoryVal T329 history
R56	TestOrProcedureReveals Test:T325 Desc:T329	
T330	BiomarkerName 1366 1368	ER
A75	HistoryVal T330 history
A76	EpisodeDescription T330 FirstOccurrence
T331	BiomarkerResult 1368 1369;1388 1391	+ 75%
A74	HistoryVal T331 history
A77	EpisodeDescription T331 FirstOccurrence
A78	BiomarkerResultVal T331 Positive
R57	BiomarkerRel Arg1:T330 Arg2:T331	
T332	BiomarkerName 1394 1396	PR
A79	HistoryVal T332 history
A80	EpisodeDescription T332 FirstOccurrence
T333	BiomarkerResult 1396 1397;1416 1419	+ 75%
A81	HistoryVal T333 history
A82	EpisodeDescription T333 FirstOccurrence
A83	BiomarkerResultVal T333 Positive
R58	BiomarkerRel Arg1:T332 Arg2:T333	
T334	BiomarkerName 1422 1426	HER2
A84	HistoryVal T334 history
A85	EpisodeDescription T334 FirstOccurrence
T335	BiomarkerResult 1426 1427	-
A86	HistoryVal T335 history
A87	EpisodeDescription T335 FirstOccurrence
A88	BiomarkerResultVal T335 Negative
T336	Pathology 1446 1451	Ki-67
A89	IntentVal T336 diagnosis
T337	RadPathResult 1452 1454	5%
A90	RadPathResultVal T337 InitialCancerDiagnosis
R59	ResultOfTest Desc:T337 Test:T336	
T339	RadPathResult 1440 1443	1.0
A92	RadPathResultVal T339 InitialCancerDiagnosis
R61	TestOrProcedureReveals Test:T325 Desc:T330	
R62	TestOrProcedureReveals Test:T325 Desc:T332	
R63	TestOrProcedureReveals Test:T325 Desc:T334	
T340	Datetime 1459 1467	08/10/13
T341	Radiology 1489 1506	digital mammogram
A93	IntentVal T341 diagnosis
T342	Site 1468 1477	Bilateral
R64	SiteOf Arg1:T342 Arg2:T341	
T343	RadPathResult 1508 1568	Extensive, segmentally distributed, clustered calcifications
A94	RadPathResultVal T343 InitialCancerDiagnosis
R65	ResultOfTest Desc:T343 Test:T341	
T344	Site 1590 1610;1619 1625	upper outer quadrant breast
T345	Laterality 1614 1618	left
R66	LateralityOfSite Arg1:T345 Arg2:T344	
R67	SiteOf Arg1:T344 Arg2:T343	
T346	Size 1570 1575	13 cm
A95	HistoryVal T346 history
A96	EpisodeDescription T346 FirstOccurrence
T347	RadPathResult 1627 1685	associated focal, poorly defined, dense and irregular mass
A97	RadPathResultVal T347 InitialCancerDiagnosis
T348	Size 1687 1693	2.3 cm
A98	HistoryVal T348 history
A99	EpisodeDescription T348 FirstOccurrence
T349	Site 1722 1742;1751 1757	upper outer quadrant breast
T350	Laterality 1746 1750	left
R68	LateralityOfSite Arg1:T350 Arg2:T349	
R69	SiteOf Arg1:T349 Arg2:T347	
R70	ResultOfTest Desc:T347 Test:T341	
T351	Radiology 1773 1775	US
A100	IntentVal T351 staging
T352	Site 1764 1772	axillary
T353	Laterality 1759 1763	Left
R71	LateralityOfSite Arg1:T353 Arg2:T352	
R72	SiteOf Arg1:T352 Arg2:T351	
T355	RadPathResult 1807 1846	focal, nodular thickening of parenchyma
A103	HistoryVal T355 history
A104	EpisodeDescription T355 FirstOccurrence
T356	Size 1848 1854	1.8 cm
A105	HistoryVal T356 history
A106	EpisodeDescription T356 FirstOccurrence
T357	Size 1859 1865	1.9 cm
A107	HistoryVal T357 history
A108	EpisodeDescription T357 FirstOccurrence
A109	RadPathResultVal T355 InitialCancerDiagnosis
R74	ResultOfTest Desc:T355 Test:T351	
T358	Pathology 1868 1877;1895 1901	US-guided biopsy
A110	IntentVal T358 staging
T359	Site 1883 1894	axillary LN
T360	Laterality 1878 1882	left
R75	LateralityOfSite Arg1:T360 Arg2:T359	
R76	SiteOf Arg1:T359 Arg2:T358	
T361	Histology 1914 1923	carcinoma
A111	HistoryVal T361 history
A112	EpisodeDescription T361 FirstOccurrence
T362	Metastasis 1903 1913	Metastatic
A113	HistoryVal T362 history
A114	EpisodeDescription T362 FirstOccurrence
R77	TestOrProcedureReveals Test:T358 Desc:T362	
R78	TestOrProcedureReveals Test:T358 Desc:T361	
T363	BiomarkerName 1929 1931	ER
A115	HistoryVal T363 history
A116	EpisodeDescription T363 FirstOccurrence
T364	BiomarkerResult 1931 1932;1953 1956	+ 75%
A117	HistoryVal T364 history
A118	EpisodeDescription T364 FirstOccurrence
A119	BiomarkerResultVal T364 Positive
R79	BiomarkerRel Arg1:T363 Arg2:T364	
T365	BiomarkerName 1959 1961	PR
A120	HistoryVal T365 history
A121	EpisodeDescription T365 FirstOccurrence
T366	BiomarkerResult 1961 1962;1980 1984	+ >75%
A122	HistoryVal T366 history
A123	EpisodeDescription T366 FirstOccurrence
A124	BiomarkerResultVal T366 Positive
T367	BiomarkerName 1987 1991	HER2
A125	HistoryVal T367 history
A126	EpisodeDescription T367 FirstOccurrence
T368	BiomarkerResult 1991 1992	-
A127	HistoryVal T368 history
A128	EpisodeDescription T368 FirstOccurrence
A129	BiomarkerResultVal T368 Negative
R80	BiomarkerRel Arg1:T367 Arg2:T368	
R81	BiomarkerRel Arg1:T365 Arg2:T366	
R82	TestOrProcedureReveals Test:T358 Desc:T363	
R83	TestOrProcedureReveals Test:T358 Desc:T365	
R84	TestOrProcedureReveals Test:T358 Desc:T367	
T370	RadPathResult 2005 2009	1.02
A130	RadPathResultVal T370 InitialCancerDiagnosis
T371	Pathology 2012 2017	Ki-67
A131	RadPathResultVal T371 InitialCancerDiagnosis
T372	RadPathResult 2018 2020	5%
A132	RadPathResultVal T372 InitialCancerDiagnosis
A133	IntentVal T371 staging
R86	ResultOfTest Desc:T372 Test:T371	
T373	Datetime 2025 2033	09/08/13
T374	ProcedureName 2051 2074	skin-sparing mastectomy
A135	IntentVal T374 treatment-curative
A136	TreatmentTypeVal T374 local
A137	IsTumorRemaining T374 no
T375	Site 2044 2050	breast
T376	Laterality 2034 2043	Bilateral
R87	LateralityOfSite Arg1:T376 Arg2:T375	
R88	SiteOf Arg1:T375 Arg2:T374	
R89	HappensAtOnDuring Arg1:T374 Arg2:T373	
T377	ProcedureName 2091 2095;2101 2105	SLNB DIEP
A138	IntentVal T377 staging
A139	TreatmentTypeVal T377 local
T378	Site 2082 2090	axillary
T379	Laterality 2077 2081	left
R90	LateralityOfSite Arg1:T379 Arg2:T378	
R91	SiteOf Arg1:T378 Arg2:T377	
R92	TestOrProcedureConductedForProblem Test:T374 Prob:T361	
R93	TestOrProcedureConductedForProblem Test:T377 Prob:T361	
T380	Histology 2136 2159	IDC micropapillary type
A140	HistoryVal T380 history
A141	EpisodeDescription T380 FirstOccurrence
T381	Grade 2134 2135	2
A142	HistoryVal T381 history
A143	EpisodeDescription T381 FirstOccurrence
T382	Size 2121 2127	8.0 cm
A144	HistoryVal T382 history
A145	EpisodeDescription T382 FirstOccurrence
T383	Site 2112 2118	breast
T384	Laterality 2107 2111	left
R94	LateralityOfSite Arg1:T384 Arg2:T383	
R95	SiteOf Arg1:T383 Arg2:T380	
R99	TestOrProcedureReveals Test:T351 Desc:T356	
R100	TestOrProcedureReveals Test:T351 Desc:T357	
R101	TestOrProcedureReveals Test:T341 Desc:T346	
R102	TestOrProcedureReveals Test:T341 Desc:T348	
R103	TestOrProcedureReveals Test:T318 Desc:T322	
T385	MarginStatus 2188 2193	clear
A146	MarginVal T385 MoreThan2mm(Neg)
R104	ProcedureDesc Procedure:T385 Desc:T374	
T386	Histology 2222 2226	DCIS
A147	HistoryVal T386 history
A148	EpisodeDescription T386 FirstOccurrence
T387	LymphNodeInvolvement 2236 2243	7/16 LN
A149	HistoryVal T387 history
A150	EpisodeDescription T387 FirstOccurrence
T354	LymphNodeInvolvement 1777 1792	Two adjacent LN
A101	HistoryVal T354 history
A102	EpisodeDescription T354 FirstOccurrence
R73	TestOrProcedureReveals Test:T351 Desc:T354	
R105	SiteOf Arg1:T352 Arg2:T354	
T388	Size 2246 2252	1.2 cm
A151	HistoryVal T388 history
A152	EpisodeDescription T388 FirstOccurrence
R96	TestOrProcedureReveals Test:T374 Desc:T380	
R97	TestOrProcedureReveals Test:T374 Desc:T381	
R98	TestOrProcedureReveals Test:T374 Desc:T382	
R106	TestOrProcedureReveals Test:T374 Desc:T386	
R107	TestOrProcedureReveals Test:T377 Desc:T387	
R108	TestOrProcedureReveals Test:T377 Desc:T388	
T389	TNM 2283 2289	pT3pN2
A153	HistoryVal T389 history
A154	EpisodeDescription T389 FirstOccurrence
T390	Site 2297 2303	breast
T391	Laterality 2291 2296	right
R109	LateralityOfSite Arg1:T391 Arg2:T390	
R110	TestOrProcedureReveals Test:T374 Desc:T389	
T392	Histology 2309 2318	carcinoma
A155	NegationModalityVal T392 negated
R111	SiteOf Arg1:T390 Arg2:T392	
T393	Datetime 2322 2330	09/17/13
T394	Radiology 2331 2351	Whole body bone scan
A156	IntentVal T394 staging
R112	HappensAtOnDuring Arg1:T393 Arg2:T394	
T395	Metastasis 2459 2469	metastatic
A157	NegationModalityVal T395 negated
A158	HistoryVal T395 history
A159	EpisodeDescription T395 FirstOccurrence
R113	TestOrProcedureReveals Test:T394 Desc:T395	
T396	Datetime 2482 2490	09/18/13
T397	Radiology 2491 2497	CT CAP
A160	IntentVal T397 staging
T398	Metastasis 2514 2524	metastases
A161	NegationModalityVal T398 negated
A162	HistoryVal T398 history
A163	EpisodeDescription T398 FirstOccurrence
R114	TestOrProcedureReveals Test:T397 Desc:T398	
R115	HappensAtOnDuring Arg1:T396 Arg2:T397	
T399	Datetime 2529 2537	11/12/13
T400	MedicationRegimen 2551 2575	dense Adriamycin/cytoxan
A164	TreatmentContinuityVal T400 discontinued_early
A165	TreatmentTypeVal T400 adjuvant
A166	TreatmentIntentVal T400 curative
T401	Cycles 2617 2618	3
R116	TreatmentDesc Therapy:T400 Desc:T401	
R117	TreatmentAdministeredForProblem Treatment:T400 Prob:T380	
T402	Symptom 2639 2645	nausea
A167	IsPresentOnFirstCancerDiagnosis T402 no
A168	IsCausedByDiagnosedCancer T402 no
A169	ChronicVal T402 non-chronic
A170	ContinuityVal T402 new
T403	Symptom 2647 2655	vomiting
A171	IsPresentOnFirstCancerDiagnosis T403 no
A172	IsCausedByDiagnosedCancer T403 no
A173	ChronicVal T403 non-chronic
A174	ContinuityVal T403 new
T404	Symptom 2657 2663	fevers
A175	IsPresentOnFirstCancerDiagnosis T404 no
A176	IsCausedByDiagnosedCancer T404 no
A177	ChronicVal T404 non-chronic
A178	ContinuityVal T404 new
T405	Symptom 2665 2671	chills
A179	IsPresentOnFirstCancerDiagnosis T405 no
A180	IsCausedByDiagnosedCancer T405 no
A181	ChronicVal T405 non-chronic
A182	ContinuityVal T405 new
T406	Symptom 2683 2702	diffused body pains
A183	IsPresentOnFirstCancerDiagnosis T406 no
A184	IsCausedByDiagnosedCancer T406 no
A185	ChronicVal T406 non-chronic
A186	ContinuityVal T406 new
R118	ConditionOrTreatmentCausesProblem Treatment:T400 Prob:T402	
R119	ConditionOrTreatmentCausesProblem Treatment:T400 Prob:T403	
R121	ConditionOrTreatmentCausesProblem Treatment:T400 Prob:T404	
R120	ConditionOrTreatmentCausesProblem Treatment:T400 Prob:T405	
R122	ConditionOrTreatmentCausesProblem Treatment:T400 Prob:T406	
T407	Datetime 2717 2725	12/18/13
T408	Radiology 2726 2732	CT CAP
A187	IntentVal T408 TreatmentAssessment
R123	HappensAtOnDuring Arg1:T407 Arg2:T408	
T409	Radiology 3088 3090	US
A188	IntentVal T409 TreatmentAssessment
T410	Site 3081 3087	breast
T411	Laterality 3071 3080	Bilateral
R124	LateralityOfSite Arg1:T411 Arg2:T410	
R125	SiteOf Arg1:T410 Arg2:T409	
R126	HappensAtOnDuring Arg1:T407 Arg2:T409	
T412	Datetime 3192 3200	03/10/15
T413	Radiology 3201 3207	CT CAP
A189	IntentVal T413 TreatmentAssessment
R127	HappensAtOnDuring Arg1:T412 Arg2:T413	
T414	Datetime 3576 3584	03/21/15
T415	Pathology 3585 3594;3611 3617	US-guided biopsy
A190	IntentVal T415 diagnosis
T416	Site 3601 3610	breast LN
T417	Laterality 3595 3600	right
R128	LateralityOfSite Arg1:T417 Arg2:T416	
R129	SiteOf Arg1:T416 Arg2:T415	
T418	RadPathResult 3619 3651	Benign axillary node hyperplasia
A191	RadPathResultVal T418 DiseaseStability
R130	ResultOfTest Desc:T418 Test:T415	
R131	HappensAtOnDuring Arg1:T414 Arg2:T415	
T419	RadPathResult 3209 3572	increased size of mildly hypermetabolic right deep pectoral and axillary LN (1.4 cm short axis MAX suv 4.9), mildly hypermetabolic right axillary LN (1.1 short axis MAX suv 4.9) are larger, area of right outer lower breast central fat density (4.3 x 4.9 cm SUV max 4.1) most compatible with fat necrosis, similar area is seen in upper and lower medial left breast
A192	RadPathResultVal T419 Unclear
R132	ResultOfTest Desc:T419 Test:T413	
T420	RadPathResult 2734 3068	Soft tissue swelling of bilateral breast reconstructions without obvious loculated fluid collection in visualized lower breast reconstructions, region of abdominoplasty wound in midline there is a sinus tract extending to open would on skin filled with fluid (4.1 x 2.2 x 1.3 cm), induration and soft tissue swelling about this region
A193	RadPathResultVal T420 DiseaseStability
R133	ResultOfTest Desc:T420 Test:T408	
T421	RadPathResult 3092 3187	Moderate bilateral subcutaneous soft tissue swelling; no evidence of loculated fluid collection
A194	RadPathResultVal T421 DiseaseStability
R134	ResultOfTest Desc:T421 Test:T409	
T422	Datetime 3655 3659	2015
T423	MedicationName 3678 3684	Lupron
A195	TreatmentContinuityVal T423 started
A196	TreatmentTypeVal T423 adjuvant
A197	TreatmentIntentVal T423 curative
A198	TreatmentCategory T423 AntiNeoPlastics
T424	MedicationName 3702 3712	exemestane
A199	TreatmentContinuityVal T424 started
A200	TreatmentTypeVal T424 adjuvant
A201	TreatmentIntentVal T424 curative
A202	TreatmentCategory T424 AntiNeoPlastics
T425	MedicationName 3724 3733	tamoxifen
A203	TreatmentContinuityVal T425 started
A204	TreatmentTypeVal T425 adjuvant
A205	TreatmentIntentVal T425 curative
A206	TreatmentCategory T425 AntiNeoPlastics
T426	Frequency 3671 3677	4 week
R135	Temporal Arg1:T426 Arg2:T423	
T427	Duration 3687 3696	1-2 years
R136	HappensAtOnDuring Arg1:T423 Arg2:T427	
R137	BeginsOnOrAt Arg1:T422 Arg2:T423	
R138	BeginsOnOrAt Arg1:T424 Arg2:T422	
R139	BeginsOnOrAt Arg1:T425 Arg2:T422	
T428	Datetime 3750 3758	08/18/15
T429	Radiology 3759 3761	CT
T430	Site 3762 3767	chest
A207	IntentVal T429 screening
R140	SiteOf Arg1:T430 Arg2:T429	
R141	HappensAtOnDuring Arg1:T429 Arg2:T428	
T431	RadPathResult 3769 3816	No pulmonary embolus or other acute abnormality
A208	RadPathResultVal T431 Others
R142	ResultOfTest Desc:T431 Test:T429	
T432	Datetime 3821 3829	09/13/15
T433	Radiology 3840 3842	US
A209	IntentVal T433 screening
T434	Site 3830 3839	Bilateral
R143	HappensAtOnDuring Arg1:T432 Arg2:T433	
R144	SiteOf Arg1:T434 Arg2:T433	
T435	RadPathResult 3853 3908;3911 3945	Previously examined right axillary LN decreased in size with decreased cortical thickening
A210	RadPathResultVal T435 DiseaseStability
R145	ResultOfTest Desc:T435 Test:T433	
T436	Datetime 4002 4011	June 2018
T437	Symptom 4042 4046	lump
A211	IsPresentOnFirstCancerDiagnosis T437 no
A212	IsCausedByDiagnosedCancer T437 yes
A213	ChronicVal T437 non-chronic
A214	ContinuityVal T437 new
T438	Site 4035 4041	breast
T439	Laterality 4030 4034	left
R146	LateralityOfSite Arg1:T439 Arg2:T438	
R147	SiteOf Arg1:T438 Arg2:T437	
T440	Datetime 4108 4116	10/26/18
A215	IntentVal T440 diagnosis
T441	Radiology 4129 4131	US
A216	IntentVal T441 diagnosis
T442	Site 4122 4128	breast
T443	Laterality 4117 4121	Left
R148	LateralityOfSite Arg1:T443 Arg2:T442	
R149	SiteOf Arg1:T442 Arg2:T441	
R150	HappensAtOnDuring Arg1:T441 Arg2:T440	
R151	BeginsOnOrAt Arg1:T436 Arg2:T437	
T444	RadPathResult 4145 4175	Irregular lobulated solid mass
A217	RadPathResultVal T444 Progression
R152	ResultOfTest Desc:T444 Test:T441	
T445	Size 4177 4195	3.1 x 1.8 x 3.0 cm
A218	HistoryVal T445 new
A219	EpisodeDescription T445 Recurrence
T446	RadPathResult 4214 4218	mass
A220	RadPathResultVal T446 Progression
T447	Size 4220 4238	1.2 x 0.9 x 0.9 cm
A221	HistoryVal T447 new
A222	EpisodeDescription T447 Recurrence
R153	TestOrProcedureReveals Test:T441 Desc:T445	
R154	TestOrProcedureReveals Test:T441 Desc:T447	
R155	ResultOfTest Desc:T446 Test:T441	
T448	Site 4243 4274	1:00 position, 7 cm from nipple
R156	SiteOf Arg1:T448 Arg2:T444	
T449	Pathology 4318 4334	US-guided biopsy
A223	IntentVal T449 diagnosis
T451	Site 4338 4342;4346 4359;4368 4374	mass 2:00 position breast
T452	Laterality 4363 4367	left
R157	LateralityOfSite Arg1:T452 Arg2:T451	
T453	Histology 4384 4387	IDC
A225	HistoryVal T453 new
A226	EpisodeDescription T453 Recurrence
T454	Grade 4382 4383	2
A227	HistoryVal T454 new
A228	EpisodeDescription T454 Recurrence
T455	BiomarkerName 4388 4390	ER
A229	HistoryVal T455 new
A230	EpisodeDescription T455 Recurrence
T456	BiomarkerName 4399 4401	PR
A231	HistoryVal T456 new
A232	EpisodeDescription T456 Recurrence
T457	BiomarkerName 4410 4414	HER2
A233	HistoryVal T457 new
A234	EpisodeDescription T457 Recurrence
T458	BiomarkerResult 4390 4391;4393 4396	+ 95%
A235	HistoryVal T458 new
A236	EpisodeDescription T458 Recurrence
A237	BiomarkerResultVal T458 Positive
T459	BiomarkerResult 4401 4402;4404 4407	+ 95%
A238	HistoryVal T459 new
A239	EpisodeDescription T459 Recurrence
A240	BiomarkerResultVal T459 Positive
T460	BiomarkerResult 4414 4415	-
A241	HistoryVal T460 new
A242	EpisodeDescription T460 Recurrence
A243	BiomarkerResultVal T460 Negative
T461	Pathology 4425 4430	Ki-67
A244	IntentVal T461 diagnosis
T462	RadPathResult 4431 4438	30%-40%
R160	ResultOfTest Desc:T462 Test:T461	
R161	BiomarkerRel Arg1:T457 Arg2:T460	
R162	BiomarkerRel Arg1:T456 Arg2:T459	
R163	BiomarkerRel Arg1:T455 Arg2:T458	
R158	SiteOf Arg1:T451 Arg2:T449	
R159	TestOrProcedureReveals Test:T449 Desc:T454	
R164	TestOrProcedureReveals Test:T449 Desc:T453	
R165	TestOrProcedureReveals Test:T449 Desc:T455	
R166	TestOrProcedureReveals Test:T449 Desc:T456	
R167	TestOrProcedureReveals Test:T449 Desc:T457	
T450	Datetime 4442 4450	01/27/19
T463	Radiology 4451 4457	PET/CT
A224	IntentVal T463 staging
R168	HappensAtOnDuring Arg1:T450 Arg2:T463	
T464	RadPathResult 4471 4488	subcutaneous mass
A245	RadPathResultVal T464 Progression
T465	Site 4464 4470	breast
T466	Laterality 4459 4463	Left
R169	LateralityOfSite Arg1:T466 Arg2:T465	
R170	SiteOf Arg1:T465 Arg2:T464	
R171	ResultOfTest Desc:T464 Test:T463	
T467	Size 4490 4502	2.1 x 3.2 cm
A246	HistoryVal T467 new
A247	EpisodeDescription T467 Recurrence
T468	LymphNodeInvolvement 4513 4531	left axillary node
A248	HistoryVal T468 new
A249	EpisodeDescription T468 Recurrence
T469	Size 4533 4545	1.3 x 1.4 cm
A250	HistoryVal T469 new
A251	EpisodeDescription T469 Recurrence
T470	LymphNodeInvolvement 4556 4585	left level 5B LN conglomerate
A252	HistoryVal T470 new
A253	EpisodeDescription T470 Recurrence
T471	Size 4587 4599	1.8 x 2.5 cm
A254	HistoryVal T471 new
A255	EpisodeDescription T471 Recurrence
T472	LymphNodeInvolvement 4611 4635	left internal mammary LN
A256	HistoryVal T472 new
A257	EpisodeDescription T472 Recurrence
T473	Size 4637 4649	1.2 x 2.0 cm
A258	HistoryVal T473 new
A259	EpisodeDescription T473 Recurrence
T474	RadPathResult 4660 4770	left axillary, left supraclavicular, left level VB and left internal mammary hypermetabolic LAD are suspicious
A260	RadPathResultVal T474 Progression
T475	Metastasis 4775 4785	metastatic
A261	HistoryVal T475 new
A262	EpisodeDescription T475 Recurrence
R172	TestOrProcedureReveals Test:T463 Desc:T468	
R173	TestOrProcedureReveals Test:T463 Desc:T467	
R174	TestOrProcedureReveals Test:T463 Desc:T469	
R175	TestOrProcedureReveals Test:T463 Desc:T470	
R176	TestOrProcedureReveals Test:T463 Desc:T471	
R177	TestOrProcedureReveals Test:T463 Desc:T472	
R178	TestOrProcedureReveals Test:T463 Desc:T473	
R179	TestOrProcedureReveals Test:T463 Desc:T475	
R180	ResultOfTest Desc:T474 Test:T463	
T476	PatientCharacteristics 4923 4931	menarche
T477	Age 4935 4937	11
R181	BeginsOnOrAt Arg1:T476 Arg2:T477	
T478	PatientCharacteristics 5060 5075	first pregnancy
T479	Age 5083 5085	19
R182	BeginsOnOrAt Arg1:T478 Arg2:T479	
T480	PatientCharacteristics 4996 5000	G5P3
T481	PatientCharacteristics 5006 5019	two abortions
T482	Symptom 5109 5136	irregular menstrual periods
T483	ClinicalCondition 5190 5215	multiple medical problems
A263	ExperiencerVal T483 family
T484	Employment 5235 5245	unemployed
A264	IsStoppedOrContinuing T484 stopped
T485	MedicationName 5343 5353	gapabentin
T486	Symptom 5358 5366;5373 5388	numbness deep sharp pain
A265	IsPresentOnFirstCancerDiagnosis T486 no
R183	TreatmentAdministeredForProblem Treatment:T485 Prob:T486	
T487	Site 5396 5401	elbow
R184	SiteOf Arg1:T487 Arg2:T486	
T488	Frequency 5507 5516	2x a week
R185	Temporal Arg1:T485 Arg2:T488	
T489	Symptom 5613 5617	pain
A266	IsCausedByDiagnosedCancer T489 no
A267	ContinuityVal T489 stable
T490	Site 5608 5612	back
R186	SiteOf Arg1:T490 Arg2:T489	
T491	Symptom 5633 5638	aches
T492	Frequency 5622 5632	occasional
R187	Temporal Arg1:T491 Arg2:T492	
T493	Site 5656 5672	knees and ankles
T494	Laterality 5646 5655	bilateral
R188	LateralityOfSite Arg1:T494 Arg2:T493	
R189	SiteOf Arg1:T493 Arg2:T491	
A268	ChronicVal T489 chronic
T495	PatientCharacteristics 5754 5771	menstrual periods
T496	MedicationName 5710 5716	Lupron
A269	TreatmentContinuityVal T496 started
A270	TreatmentTypeVal T496 adjuvant
A271	TreatmentIntentVal T496 curative
A272	TreatmentCategory T496 AntiNeoPlastics
T497	MedicationName 5814 5820	Lupron
A273	TreatmentContinuityVal T497 discontinued_early
A274	TreatmentTypeVal T497 adjuvant
A275	TreatmentIntentVal T497 curative
A276	TreatmentCategory T497 AntiNeoPlastics
T498	Insurance 5841 5850	insurance
A277	IsStoppedOrContinuing T498 stopped
R190	TreatmentDiscontinuedBecauseOf Therapy:T497 Reason:T498	
T499	MedicationName 5893 5902	tamoxifen
A278	TreatmentContinuityVal T499 started
A279	TreatmentTypeVal T499 adjuvant
A280	TreatmentIntentVal T499 curative
A281	TreatmentCategory T499 AntiNeoPlastics
T500	MedicationName 5907 5917	exemestane
A282	TreatmentContinuityVal T500 started
A283	TreatmentTypeVal T500 adjuvant
A284	TreatmentIntentVal T500 curative
A285	TreatmentCategory T500 AntiNeoPlastics
T501	Symptom 5935 5941	nausea
A286	IsPresentOnFirstCancerDiagnosis T501 no
A287	IsCausedByDiagnosedCancer T501 no
T502	Symptom 5946 5955	body pain
A288	IsPresentOnFirstCancerDiagnosis T502 no
A289	IsCausedByDiagnosedCancer T502 no
R191	ConditionOrTreatmentCausesProblem Treatment:T499 Prob:T501	
R192	ConditionOrTreatmentCausesProblem Treatment:T500 Prob:T501	
R193	ConditionOrTreatmentCausesProblem Treatment:T499 Prob:T502	
R194	ConditionOrTreatmentCausesProblem Treatment:T500 Prob:T502	
T503	Symptom 6062 6066	mass
A290	IsCausedByDiagnosedCancer T503 yes
T504	Site 6079 6085	breast
T505	Laterality 6074 6078	left
R195	LateralityOfSite Arg1:T505 Arg2:T504	
R196	SiteOf Arg1:T504 Arg2:T503	
T506	Symptom 6171 6175	lump
T507	Site 6188 6192	neck
T508	Laterality 6183 6187	left
R197	LateralityOfSite Arg1:T508 Arg2:T507	
R198	SiteOf Arg1:T507 Arg2:T506	
T509	Symptom 6129 6142	discoloration
T510	ClinicalCondition 6417 6436	Breast cancer (HCC)
T511	Datetime 6437 6441	2014
R199	HappensAtOnDuring Arg1:T510 Arg2:T511	
T512	ClinicalCondition 6446 6464	HTN (hypertension)
A291	ChronicVal T512 chronic
T513	ClinicalCondition 6470 6492	Hyperemesis gravidarum
T514	ProcedureName 6555 6565	MASTECTOMY
A292	IntentVal T514 treatment-curative
A293	TreatmentTypeVal T514 local
A294	TreatmentCategory T514 Others
A295	IsTumorRemaining T514 no
T515	Site 6566 6575	Bilateral
R200	SiteOf Arg1:T515 Arg2:T514	
T516	Datetime 6576 6580	2014
R201	HappensAtOnDuring Arg1:T514 Arg2:T516	
T517	ClinicalCondition 6644 6652	Lymphoma
A296	ExperiencerVal T517 family
T518	ClinicalCondition 6666 6679	Breast cancer
A297	NegationModalityVal T518 negated
A298	ExperiencerVal T518 family
T519	Tobacco 7181 7188	Smoking
A299	IsStoppedOrContinuing T519 continuing
T520	ConsumptionQuantity 7243 7252	3 cig/day
T521	Frequency 7205 7214	Every Day
R202	Temporal Arg1:T519 Arg2:T521	
R203	ConsumptionQuantityRel Arg1:T519 Arg2:T520	
T522	Alcohol 7289 7296	Alcohol
A300	IsStoppedOrContinuing T522 continuing
T523	Frequency 7321 7338	2-4 times a month
R204	Temporal Arg1:T523 Arg2:T522	
T524	Drugs 7343 7347	Drug
A301	NegationModalityVal T524 negated
T525	SectionSkip 8085 8220	The patient underwent menarche at 11 years of age.  She took OCP for <1 year.  She is G5P3.  Her first pregnancy was at 19 years of age
A302	SectionSkipType T525 copy_forward
T526	Symptom 8228 8316	regular periods, sometimes 3 week cycle, sometimes lasts over a week, sometimes spotting
T527	Allergy 8885 8910	Hydrocodone-Acetaminophen
T528	Allergy 8916 8925	Ibuprofen
T529	Symptom 9145 9172	Irregular menstrual periods
T530	Symptom 9205 9215	joint pain
T531	Symptom 9249 9253	ache
T532	Site 9234 9248	knee and ankle
T533	Laterality 9224 9233	Bilateral
R205	LateralityOfSite Arg1:T533 Arg2:T532	
R206	SiteOf Arg1:T532 Arg2:T531	
T534	Symptom 9269 9282	Discoloration
T535	Site 9299 9305	breast
T536	Laterality 9294 9298	left
R207	LateralityOfSite Arg1:T536 Arg2:T535	
R208	SiteOf Arg1:T535 Arg2:T534	
T537	Symptom 9329 9337	Numbness
T538	Site 9357 9360	arm
T539	Laterality 9352 9356	left
R209	LateralityOfSite Arg1:T539 Arg2:T538	
R210	SiteOf Arg1:T538 Arg2:T537	
T9	Symptom 9392 9403	Hot flashes
T541	PatientCharacteristics 10778 10791	premenopausal
T542	Stage 10833 10836	III
A304	HistoryVal T542 history
A305	EpisodeDescription T542 FirstOccurrence
T543	TNM 10838 10842	T3N2
A306	HistoryVal T543 history
A307	EpisodeDescription T543 FirstOccurrence
T544	Histology 10862 10894	IDC with micropapillary features
A308	HistoryVal T544 history
A309	EpisodeDescription T544 FirstOccurrence
T545	Grade 10860 10861	2
A310	HistoryVal T545 history
A311	EpisodeDescription T545 FirstOccurrence
T540	SectionSkip 9411 9770;9773 10604	Physical Exam:    Vital Signs - BP 140/81  | Pulse 62  | Temp 36.7 C (98 F) (Temporal)  | Resp 18  | Ht 169.2 cm (5' 6.61") Comment: December 19 @ ***** | Wt (!) 107.4 kg (236 lb 12.8 oz)  | SpO2 99%  | BMI 37.52 kg/m    Constitutional - WDWN, NAD  Eyes - sclera anicteric, PERRL, EOMI  HENT - sinuses nontender, nasal mucosa intact, pharynx without erythema, stomatitis, or thrush   Lymph Nodes -  No cervical, supraclavicular or axillary lymphadenopathy  Respiratory - resonant to percussion throughout, CTA bilaterally; no wheezes, rhonchi, or crackles  Cardiovascular - Normal heart rate, normal rhythm, no murmurs, no edema  Breast - Sitting upright, there is a  6.5 x 5 cm mass located on her left upper outer quadrant at 2:00 position 7cm from center of nipple; while lying down the same mass: 4.5 x 7 cm; 3.5 x 3.5 cm mass in left lateral anterior neck   GI - Bowel sounds normal, soft; no tenderness, no distention, no HSM  Musculoskeletal - No tenderness over bones or joints.   Neurologic - Alert & oriented x 3, ambulates w/o difficulty, good strength throughout  Psychiatric - Mood stable; no HI, SI, hallucinations, paranoia, or delusions  Skin - warm without rashes or lesions
A303	SectionSkipType T540 physical_exam
T546	Site 10907 10913	breast
T547	Laterality 10902 10906	left
R211	LateralityOfSite Arg1:T547 Arg2:T546	
R212	SiteOf Arg1:T546 Arg2:T544	
T548	BiomarkerName 10844 10846	HR
A312	HistoryVal T548 history
A313	EpisodeDescription T548 FirstOccurrence
T549	BiomarkerName 10848 10852	HER2
A314	HistoryVal T549 history
A315	EpisodeDescription T549 FirstOccurrence
T550	BiomarkerResult 10846 10847	+
A316	HistoryVal T550 history
A317	EpisodeDescription T550 FirstOccurrence
A318	BiomarkerResultVal T550 Positive
T551	BiomarkerResult 10852 10853	-
A319	HistoryVal T551 history
A320	EpisodeDescription T551 FirstOccurrence
A321	BiomarkerResultVal T551 Negative
R213	SiteOf Arg1:T546 Arg2:T544	
R214	BiomarkerRel Arg1:T550 Arg2:T548	
R215	BiomarkerRel Arg1:T551 Arg2:T549	
T552	Metastasis 10989 10999	metastatic
A322	HistoryVal T552 new
A323	EpisodeDescription T552 Recurrence
T553	LymphNodeInvolvement 11016 11027	level Vb LN
A324	HistoryVal T553 new
A325	EpisodeDescription T553 Recurrence
T554	TreatmentType 11083 11099	systemic therapy
A328	TreatmentIntentVal T554 unclear
T555	DiseaseState 10957 10967	recurrence
T556	TumorTest 11054 11064	evaluation
A330	IntentVal T556 staging
T557	BiomarkerName 11228 11230	HR
A331	HistoryVal T557 new
A332	EpisodeDescription T557 Recurrence
T558	BiomarkerName 11232 11236	HER2
A333	HistoryVal T558 new
A334	EpisodeDescription T558 Recurrence
T559	ClinicalCondition 11238 11251	breast cancer
A335	ContinuityVal T559 worsening
T560	BiomarkerResult 11230 11231	+
A336	HistoryVal T560 new
A337	EpisodeDescription T560 Recurrence
A338	BiomarkerResultVal T560 Positive
T561	BiomarkerResult 11236 11237	-
A339	HistoryVal T561 new
A340	EpisodeDescription T561 Recurrence
A341	BiomarkerResultVal T561 Negative
R218	BiomarkerRel Arg1:T560 Arg2:T557	
R219	BiomarkerRel Arg1:T561 Arg2:T558	
T562	Radiology 11365 11371	PET/CT
A342	IntentVal T562 staging
T563	LymphNodeInvolvement 11397 11417	level Vb lymph nodes
A343	HistoryVal T563 new
A344	EpisodeDescription T563 Recurrence
R220	TestOrProcedureReveals Test:T562 Desc:T563	
T564	Metastasis 11443 11453	metastatic
A345	NegationModalityVal T564 uncertain_in_present
A346	HistoryVal T564 new
A347	EpisodeDescription T564 Recurrence
A326	NegationModalityVal T554 hypothetical_in_future
R221	TestOrProcedureReveals Test:T562 Desc:T564	
A327	NegationModalityVal T552 uncertain_in_present
T565	TreatmentType 11536 11552	systemic therapy
A348	NegationModalityVal T565 hypothetical_in_future
A349	TreatmentContinuityVal T565 unclear
A350	TreatmentTypeVal T565 unclear
A351	TreatmentIntentVal T565 unclear
T566	ClinicalCondition 11479 11486	disease
A352	ContinuityVal T566 worsening
R222	TreatmentAdministeredForProblem Treatment:T565 Prob:T566	
T567	Pathology 11570 11573	FNA
A353	IntentVal T567 diagnosis
R223	TestOrProcedureConductedForProblem Test:T567 Prob:T566	
T568	ClinicalCondition 11690 11693	MBC
A354	ContinuityVal T568 worsening
T569	BiomarkerName 11680 11682	HR
A355	HistoryVal T569 new
A356	EpisodeDescription T569 Recurrence
T570	BiomarkerName 11684 11688	HER2
A357	HistoryVal T570 new
A358	EpisodeDescription T570 Recurrence
T571	BiomarkerResult 11682 11683	+
A359	HistoryVal T571 new
A360	EpisodeDescription T571 Recurrence
A361	BiomarkerResultVal T571 Positive
T572	BiomarkerResult 11688 11689	-
A362	HistoryVal T572 new
A363	EpisodeDescription T572 Recurrence
A364	BiomarkerResultVal T572 Negative
R224	BiomarkerRel Arg1:T571 Arg2:T569	
R225	BiomarkerRel Arg1:T572 Arg2:T570	
T573	Symptom 11834 11844	toxicities
T574	TreatmentType 11872 11884	chemotherapy
A365	NegationModalityVal T574 hypothetical_in_future
A366	TreatmentIntentVal T574 others
T575	TreatmentType 11960 11972	chemotherapy
A367	NegationModalityVal T575 hypothetical_in_future
A368	TreatmentIntentVal T575 others
T576	Symptom 12002 12010	toxicity
A369	NegationModalityVal T576 hypothetical_in_future
A370	NegationModalityVal T573 hypothetical_in_future
R226	ConditionOrTreatmentCausesProblem Treatment:T575 Prob:T576	
T577	PatientCharacteristics 12085 12098	premenopausal
T578	BiomarkerName 12113 12115	HR
A371	HistoryVal T578 new
A372	EpisodeDescription T578 Recurrence
T579	BiomarkerResult 12115 12116	+
A373	HistoryVal T579 new
A374	EpisodeDescription T579 Recurrence
A375	BiomarkerResultVal T579 Positive
T580	ClinicalCondition 12117 12120	MBC
A376	ContinuityVal T580 worsening
R227	BiomarkerRel Arg1:T579 Arg2:T578	
T581	TreatmentType 12124 12143	ovarian suppression
A377	NegationModalityVal T581 hypothetical_in_future
A378	TreatmentIntentVal T581 others
T582	MedicationName 12152 12171	aromatase inhibitor
A379	NegationModalityVal T582 hypothetical_in_future
A380	TreatmentIntentVal T582 others
A381	TreatmentCategory T582 AntiNeoPlastics
T583	TreatmentType 12055 12080	endocrine-based treatment
A382	NegationModalityVal T583 hypothetical_in_future
A383	TreatmentIntentVal T583 others
T584	MedicationName 12209 12225	CDK 4/6 inhibito
A384	NegationModalityVal T584 hypothetical_in_future
A385	TreatmentIntentVal T584 others
A386	TreatmentCategory T584 AntiNeoPlastics
R228	TreatmentAdministeredForProblem Treatment:T581 Prob:T580	
R229	TreatmentAdministeredForProblem Treatment:T582 Prob:T580	
R230	TreatmentAdministeredForProblem Treatment:T584 Prob:T580	
T585	TreatmentType 12261 12263	OS
A387	NegationModalityVal T585 planned_in_future
A388	TreatmentIntentVal T585 others
T586	MedicationName 12302 12304	AI
A389	NegationModalityVal T586 planned_in_future
A390	TreatmentIntentVal T586 others
A391	TreatmentCategory T586 AntiNeoPlastics
R231	TreatmentAdministeredForProblem Treatment:T586 Prob:T580	
R232	TreatmentAdministeredForProblem Treatment:T585 Prob:T580	
T587	Pathology 12483 12486	FNA
A392	IntentVal T587 diagnosis
T588	Site 12491 12495;12504 12525	mass lateral anterior neck
T589	Laterality 12499 12503	left
R233	LateralityOfSite Arg1:T589 Arg2:T588	
R234	SiteOf Arg1:T588 Arg2:T587	
T590	MedicationName 12543 12552	goserelin
A393	NegationModalityVal T590 planned_in_future
A394	TreatmentIntentVal T590 others
A395	TreatmentCategory T590 AntiNeoPlastics
T591	MedicationName 12566 12568	AI
A396	NegationModalityVal T591 planned_in_future
A397	TreatmentIntentVal T591 others
A398	TreatmentCategory T591 AntiNeoPlastics
T592	DiseaseState 11218 11227	recurrent
T338	Pathology 1429 1433	FISH
A91	IntentVal T338 diagnosis
R5	ResultOfTest Desc:T339 Test:T338	
T369	Pathology 1994 1998	FISH
A134	IntentVal T369 diagnosis
R60	ResultOfTest Desc:T370 Test:T369	
A399	IsStoppedOrContinuing T303 stopped
A400	DiseaseStateVal T274 progression-recurrence
A401	DiseaseStateVal T555 progression-recurrence
R85	TestOrProcedureConductedForProblem Test:T556 Prob:T555	
R216	TreatmentAdministeredForProblem Treatment:T554 Prob:T555	
A6	DiseaseStateVal T592 progression-recurrence
R217	SizeOf Arg1:T356 Arg2:T355	
R235	SizeOf Arg1:T357 Arg2:T355	
R236	SizeOf Arg1:T348 Arg2:T347	
R237	SizeOf Arg1:T346 Arg2:T343	
R238	SizeOf Arg1:T322 Arg2:T321	
R239	SizeOf Arg1:T382 Arg2:T380	
R240	SizeOf Arg1:T388 Arg2:T386	
R241	SizeOf Arg1:T445 Arg2:T444	
R242	SizeOf Arg1:T447 Arg2:T446	
R243	SizeOf Arg1:T467 Arg2:T464	
R244	SizeOf Arg1:T471 Arg2:T470	
R245	SizeOf Arg1:T469 Arg2:T468	
R246	SizeOf Arg1:T473 Arg2:T472	
R247	HappensAtOnDuring Arg1:T305 Arg2:T304	
T593	Symptom 1288 1303	palpable nodule
A329	IsPresentOnFirstCancerDiagnosis T593 yes
A402	IsCausedByDiagnosedCancer T593 yes
R248	SizeOf Arg1:T326 Arg2:T593	
R249	HappensAtOnDuring Arg1:T340 Arg2:T341	
R250	HappensAtOnDuring Arg1:T373 Arg2:T377	
T594	LocalInvasion 2161 2164	LVI
A403	HistoryVal T594 history
A404	EpisodeDescription T594 FirstOccurrence
R251	TestOrProcedureReveals Test:T374 Desc:T594	
R252	BeginsOnOrAt Arg1:T399 Arg2:T400	
T595	Pathology 4417 4420	IHC
A405	IntentVal T595 diagnosis
T596	RadPathResult 4421 4423	1+
R253	ResultOfTest Desc:T596 Test:T595	
T597	DiseaseState 3987 3997	Recurrence
A406	DiseaseStateVal T597 progression-recurrence
T598	PatientCharacteristics 5025 5033	children
T599	Age 5038 5040	12
T600	Age 5042 5044	10
T601	Age 5049 5050	7
T602	Symptom 5557 5561;5567 5573	pain 5-6/10
A407	NegationModalityVal T495 negated
T603	Age 10770 10772	31
A408	NegationModalityVal T556 planned_in_future
R264	TumorDesc TumorDetails:T559 Desc:T557	
R265	TumorDesc TumorDetails:T559 Desc:T558	
R267	InclusionCriteriaFor Arg1:T577 Arg2:T581	
R268	InclusionCriteriaFor Arg1:T577 Arg2:T582	
R269	InclusionCriteriaFor Arg1:T577 Arg2:T584	
R270	InclusionCriteriaFor Arg1:T578 Arg2:T581	
R271	InclusionCriteriaFor Arg1:T578 Arg2:T582	
R272	InclusionCriteriaFor Arg1:T578 Arg2:T584	
A409	NegationModalityVal T587 planned_in_future
T604	hpi_start 0 3	ID:
T605	hpi_end 6361 6367	juice.
T606	ap_start 10737 10747	Assessment
T607	ap_end 12677 12680	OS.
